VC-backed Swiss biotechnology company ADC Therapeutics has announced its intention to float on the New York stock exchange.
LDC portfolio company Lucid Group Communications has acquired a medical communications group
TriSpan acquired the majority stake in the business in a buyout in June last year
Altor Equity Partners and Shamrock Capital will remain invested in the merged company
Hamou joins from DC Advisory, where he was co-head of the business in France since 2012